Novo Nordisk invests 8 billion DKK in expansion of Montes Claros production site in Brazil

Novo Nordisk announced an 8 billion DKK (6.4 billion reais) investment to expand its production site in Montes Claros, Brazil, adding aseptic production processes, a warehouse, and a quality control laboratory. Construction has begun and is expected to be completed in 2028, creating 600 permanent jobs.

“With this expansion of the Montes Claros site we further strengthen our global production capacity, supporting our ability to meet current and future demand for innovative medicines around the world.”novonordisk.com

• 1 source
• novonordisk.comNovo Nordisk announces 8 billion DKK investment in expansion of production facilities in Montes Claros, BrazilApr 7, 2025

Summarized from public sources; check the original articles before acting on it.